Bayar, Sezin Akca <br/><br/>
Subconjunctival bevacizumab in the impending recurrent pterygia.  [electronic resource] 

 -  International ophthalmology  Jun 2014 
 - 541-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-2630 
<br/><br/><label>Standard No.: </label>10.1007/s10792-013-9852-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Conjunctiva--blood supply<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections, Intraocular--methods<br/>Male<br/>Middle Aged<br/>Pterygium--drug therapy<br/>Recurrence